EODData

MEMBERSHIP REGISTER LOG IN

FRA, NP5: NEWRON PHARMACEUT. EO-20

07 Nov 2025
LAST:

14.78

CHANGE:
 0.06		OPEN:
15.14		HIGH:
15.14		ASK:
0.00		VOLUME:
575
CHG(%):
0.40		PREV:
14.84		LOW:
14.52		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 2515.1415.1414.5214.78575
06 Nov 2514.8414.8414.8414.840
05 Nov 2515.1815.1815.1815.18250
04 Nov 2514.8014.8014.8014.80250
31 Oct 2515.3215.3215.3215.32250
30 Oct 2515.0615.3815.0615.38250
29 Oct 2514.7614.7614.7614.76250
28 Oct 2514.6014.6014.6014.60250
27 Oct 2515.3015.3014.7014.70250
24 Oct 2515.4015.4015.4015.40250

COMPANY PROFILE

Name:NEWRON PHARMACEUT. EO-20
About:Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company's lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. The company was founded in 1999 and is headquartered in Bresso, Italy.
Sector:Healthcare
Industry:Biotechnology
Address:Via Antonio Meucci 3, Bresso, MI, Italy, 20091
Website:https://www.newron.com
ISIN:IT0004147952
LEI:8156002F8C11F80A9740

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:10.88 
Forward P/E:27.10 
Price to Sales:4.93 
Price to Book:187.34 
Profit Margin:0.42 
Operating Margin:0.11 
Return on Assets:0.51 
Return on Equity:10.87 
Revenue:59.88M 
EBITDA:26.44M 
Shares:19.96M 
Market Cap:294.99M 

TECHNICAL INDICATORS

MA5:14.981.4%
MA10:14.981.3%
MA20:15.192.8%
MA50:12.3220.0%
MA100:9.8350.4%
MA200:9.2859.3%
STO9:23.08
STO14:15.52 
RSI14:57.38
WPR14:-84.48 
MTM14:-0.98
ROC14:-0.06 
ATR:0.47 
Week High:15.323.7%
Week Low:14.521.8%
Month High:17.1816.2%
Month Low:13.9059.3%
Year High:17.1816.2%
Year Low:5.89151.1%
Volatility:23.04